Literature DB >> 19249393

The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006.

Hye-Kyung Jung1, Rok Seon Choung, G Richard Locke, Cathy D Schleck, Alan R Zinsmeister, Lawrence A Szarka, Brian Mullan, Nicholas J Talley.   

Abstract

BACKGROUND & AIMS: The epidemiology of gastroparesis is unknown. We aimed to determine the incidence, prevalence, and outcome of gastroparesis in the community.
METHODS: Using the Rochester Epidemiology Project, a medical records linkage system in Olmsted County, Minnesota, we identified county residents with potential gastroparesis. The complete medical records were reviewed by a gastroenterologist. Three diagnostic definitions were used: (1) definite gastroparesis, delayed gastric emptying by standard scintigraphy and typical symptoms for more than 3 months; (2) probable gastroparesis, typical symptoms and food retention on endoscopy or upper gastrointestinal study; (3) possible gastroparesis, typical symptoms alone or delayed gastric emptying by scintigraphy without gastrointestinal symptoms. Poisson regression was used to assess the association of incidence rates with age, sex, and calendar period.
RESULTS: Among 3604 potential cases of gastroparesis, 83 met diagnostic criteria for definite gastroparesis, 127 definite plus probable gastroparesis, and 222 any of the 3 definitions of gastroparesis. The age-adjusted (to the 2000 US white population) incidence per 100,000 person-years of definite gastroparesis for the years 1996-2006 was 2.4 (95% confidence interval [CI], 1.2-3.8) for men and 9.8 (95% CI, 7.5-12.1) for women. The age-adjusted prevalence of definite gastroparesis per 100,000 persons on January 1, 2007, was 9.6 (95% CI, 1.8-17.4) for men and 37.8 (95% CI, 23.3-52.4) for women. Overall survival was significantly lower than the age- and sex-specific expected survival computed from the Minnesota white population (P<.05).
CONCLUSIONS: Gastroparesis is an uncommon condition in the community but is associated with a poor outcome.

Entities:  

Mesh:

Year:  2008        PMID: 19249393      PMCID: PMC2705939          DOI: 10.1053/j.gastro.2008.12.047

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

1.  Effect of the menstrual cycle on gastric emptying.

Authors:  R C Gill; P D Murphy; H R Hooper; K L Bowes; Y J Kingma
Journal:  Digestion       Date:  1987       Impact factor: 3.216

2.  Influence of the menstrual cycle and of menopause on the gastric emptying rate of solids in female volunteers.

Authors:  J Monés; I Carrió; R Calabuig; M Estorch; S Sainz; L Berná; F Vilardell
Journal:  Eur J Nucl Med       Date:  1993-07

3.  The normal menstrual cycle has no effect on gastric emptying.

Authors:  M Horowitz; G J Maddern; B E Chatterton; P J Collins; O M Petrucco; R Seamark; D J Shearman
Journal:  Br J Obstet Gynaecol       Date:  1985-07

4.  Gastrointestinal transit: the effect of the menstrual cycle.

Authors:  A Wald; D H Van Thiel; L Hoechstetter; J S Gavaler; K M Egler; R Verm; L Scott; R Lester
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

5.  Dyspepsia and dyspepsia subgroups: a population-based study.

Authors:  N J Talley; A R Zinsmeister; C D Schleck; L J Melton
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

6.  Towards a less costly but accurate test of gastric emptying and small bowel transit.

Authors:  M Camilleri; A R Zinsmeister; M P Greydanus; M L Brown; M Proano
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

7.  Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.

Authors:  D A Revicki; A M Rentz; D Dubois; P Kahrilas; V Stanghellini; N J Talley; J Tack
Journal:  Aliment Pharmacol Ther       Date:  2003-07-01       Impact factor: 8.171

8.  Performance characteristics of scintigraphic transit measurements for studies of experimental therapies.

Authors:  F Cremonini; B P Mullan; M Camilleri; D D Burton; M R Rank
Journal:  Aliment Pharmacol Ther       Date:  2002-10       Impact factor: 8.171

9.  Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms.

Authors:  Albert J Bredenoord; Heather J Chial; Michael Camilleri; Brian P Mullan; Joseph A Murray
Journal:  Clin Gastroenterol Hepatol       Date:  2003-07       Impact factor: 11.382

10.  Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995-2004.

Authors:  Yize R Wang; Robert S Fisher; Henry P Parkman
Journal:  Am J Gastroenterol       Date:  2007-11-28       Impact factor: 10.864

View more
  149 in total

1.  Metoclopramide in the treatment of diabetic gastroparesis.

Authors:  Allen Lee; Braden Kuo
Journal:  Expert Rev Endocrinol Metab       Date:  2010

Review 2.  Gastroparesis: what is the current state-of-the-art for evaluation and medical management? What are the results?

Authors:  Allen Lee
Journal:  J Gastrointest Surg       Date:  2013-06-26       Impact factor: 3.452

Review 3.  Epidemiology and natural history of gastroparesis.

Authors:  Adil E Bharucha
Journal:  Gastroenterol Clin North Am       Date:  2014-12-18       Impact factor: 3.806

Review 4.  Idiopathic gastroparesis.

Authors:  Henry P Parkman
Journal:  Gastroenterol Clin North Am       Date:  2014-12-24       Impact factor: 3.806

Review 5.  Gastroparesis: Medical and Therapeutic Advances.

Authors:  Christopher M Navas; Nihal K Patel; Brian E Lacy
Journal:  Dig Dis Sci       Date:  2017-07-18       Impact factor: 3.199

6.  Per oral endoscopic pyloromyotomy for refractory gastroparesis: initial results from a single institution.

Authors:  John H Rodriguez; Ivy N Haskins; Andrew T Strong; Ryan L Plescia; Matthew T Allemang; Robert S Butler; Michael S Cline; Kevin El-Hayek; Jeffrey L Ponsky; Matthew D Kroh
Journal:  Surg Endosc       Date:  2017-05-31       Impact factor: 4.584

7.  Hyperglycemia Increases Interstitial Cells of Cajal via MAPK1 and MAPK3 Signaling to ETV1 and KIT, Leading to Rapid Gastric Emptying.

Authors:  Yujiro Hayashi; Yoshitaka Toyomasu; Siva Arumugam Saravanaperumal; Michael R Bardsley; John A Smestad; Andrea Lorincz; Seth T Eisenman; Gianluca Cipriani; Molly H Nelson Holte; Fatimah J Al Khazal; Sabriya A Syed; Gabriella B Gajdos; Kyoung Moo Choi; Gary J Stoltz; Katie E Miller; Michael L Kendrick; Brian P Rubin; Simon J Gibbons; Adil E Bharucha; David R Linden; Louis James Maher; Gianrico Farrugia; Tamas Ordog
Journal:  Gastroenterology       Date:  2017-04-21       Impact factor: 22.682

8.  Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: a retrospective study of 932 patients.

Authors:  Richard A Schatz; Qing Zhang; Nilesh Lodhia; Jonathan Shuster; Phillip P Toskes; Baharak Moshiree
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

9.  [Chronic motility disorders of the upper gastrointestinal tract in the elderly. Pharmaceutical, endoscopic and operative therapy].

Authors:  J-U Sonne; J F Erckenbrecht
Journal:  Internist (Berl)       Date:  2014-07       Impact factor: 0.743

10.  Effects of Clozapine on the Gut: Cross-Sectional Study of Delayed Gastric Emptying and Small and Large Intestinal Dysmotility.

Authors:  Susanna Every-Palmer; Stephen J Inns; Eve Grant; Pete M Ellis
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.